Introduction
Copy number variants (CNVs) are a form of genetic variation that occur when a genomic sequence is deleted or duplicated, potentially affecting both the structure and expression levels of coding sequences and playing a crucial role in evolution and adaptation [1] [2] [3] . Part of the importance of CNVs lies in the wide range of effects that they can have on the transcriptome. Increases in copy number (amplifications) encompassing the entire sequence of a gene can lead to elevated expression levels if new gene copies are associated with cis-regulatory sequences required for transcription [4] .
Alternatively, duplication or deletion of only part of a gene's sequence can lead to structural variation. For example, in humans, a CNV spanning parts of two glycophorin genes creates a novel hybrid glycophorin associated with resistance to malaria [5] . CNVs can also allow alternative variants of a gene to appear in tandem on the same chromosome through heterogeneous gene duplication, creating constitutive heterozygotes. This can be seen in the mosquitoes Anopheles gambiae and Culex pipiens, where mutations in Acetylecholinesterase-1 (Ace-1) cause resistance to carbamate and organophosphate insecticides, but carry a fitness cost in the absence of insecticide.
This cost is mitigated in heterozygotes, leading to the spread of heterogeneous Ace-1 duplications in which the mutant and wild-type alleles co-occur [6, 7] .
While the importance of CNVs is widely recognised, they typically receive less attention than single nucleotide polymorphisms (SNPs) in investigations of genetic variation, perhaps because they are more difficult to identify. Population-level genome-wide analyses of CNVs are thus rare and the extent of their impact on evolution is poorly understood (but see [8] for a worldwide study in humans).
The malaria mosquito An. gambiae and its close sister species An. coluzzii provide excellent models to study the evolution of CNVs at a population level for three reasons. First, these species are the major vectors of malaria in Sub-Saharan Africa (SSA) and are highly anthropophagic [9] . As a consequence, they are heavily targeted by insecticides used in malaria control programmes, creating intense selective pressures that drive rapid contemporary evolution. CNVs thus have an opportunity to contribute to the selective response to these pressures, providing a context in which their importance can be assessed. Second, CNVs can play a key role in the evolution of insecticide resistance due to their ability to affect gene expression and allow co-expression of wild-type and mutant alleles [10, 11] . Despite nearly two decades of genetic research into insecticide resistance, known resistance-associated SNPs are still unable to explain much of the variance in insecticide resistance [12] . CNVs potentially represent a crucial source of missing variation that can fill this gap. Third, the Anopheles gambiae 1000 Genomes project (Ag1000G) has produced whole-genome sequencing data from 1142 individual An. gambiae and An. coluzzii from multiple locations in SSA, providing a unique opportunity to conduct genome-wide searches for CNVs from across the species' distributions [13] .
The two major mechanisms of insecticide resistance are target site resistance and metabolic resistance [14] . CNVs have been found to affect all three major insecticide target site genes in insects (Ace-1: [6, 15] ; the para voltage-gated sodium channel (Vgsc): [16, 17] ; gammaaminobutyric acid (GABA) receptor: [18] ), usually combining resistant and wild-type alleles to provide resistance while mitigating its cost. However, duplications in Ace-1 are the only CNVs so far shown to play a role in Anopheles insecticide resistance, being associated with a resistanceconferring mutation and either increasing the resistance which it confers [19] or diminishing the fitness cost of the mutation [6] .
Metabolic genes whose expression levels are associated with insecticide resistance have been reported in a wide range of species [20] , but the causative genetic variants often remain unidentified. Focused studies have identified cases where CNVs play a critical role in metabolic insecticide resistance in a range of species. In Drosophila, duplication of the detoxification gene Cyp6g1 has been implicated in resistance to DDT [21] , while in Cx. quinquefasciatus resistance to permethrin is associated with increased expression of Cyp9m10, due in part to a duplication [22] Similarly, amplification of esterase genes leading to elevated expression provides increased resistance to organophosphates in the mosquitoes Cx. pipiens [23] and Aedes albopictus [24] , and to several insecticides in the peach-potato aphid Myzus persicae [25, 26] . In brown planthoppers, neofunctionalisation of a duplicated copy of Cyp6er1 has even created a novel gene variant providing resistance to the neonicotinoid imidacloprid [27] . In An. gambiae and An. coluzzii, the most import metabolic genes that have been identified as major insecticide resistance candidates to date are Gste2 [28] , Cyp6p3 [29, 30] , Cyp6m2 [29, 31, 32] , Cyp6z1 [33] and Cyp9k1 [34, 35] . If
Results
We found a total of 1557 independent CNVs in the Ag1000G phase 2 dataset using sequencing coverage data (Supplementary Data S1); 250 of these CNVs contained at least one gene, significantly more than expected by chance (P < 0.0001, null distribution determined by simulation). Out of 10,939 genes included in the analysis, 267 (2.4%) were found in at least one CNV (Supplementary Data S2). As expected, these included the well-documented duplication in the insecticide target site Ace-1. No CNVs were found in the other common insecticide target sites Vgsc or GABA.
CNVs are enriched for potential metabolic resistance genes.
Of the 267 genes found in CNVs (Supplementary Data S2), 28 were candidate metabolic resistance genes (defined as a cytochrome P450, glutathione-S-transferase or carboxylesterase, and referred to as "metabolic detox genes" from here on). Because many related genes occur in clusters, and are therefore not independently included in CNV events, we counted the number of CNVs that included at least one metabolic detox gene. Of the 250 CNVs that contained any genes, 27 contained at least one metabolic detox gene, significantly more than expected by chance (P < 0.0001, null distribution determined by simulation). While there was some variation between populations in the number of metabolic detox genes found in CNVs (Table 1) , this was not significant (Fisher's exact test: P = 0.08).
Analysis of Gene Ontology (GO) terms for genes encompassed by CNVs showed enrichment for cytochrome P450s. Genes found in CNVs were enriched for 13 molecular function GO terms after multiple correction to a Q-value threshold of 0.05 (Supplementary Data S3), primarily reflecting an enrichment for two classes of genes: cytochrome P450s (significant GO terms included monoxygenase activity, heme binding, iron ion binding, oxidoreductase activity) and proteases (significant GO terms included several forms of peptidase activity). No GO terms from biological process or cellular compartment ontologies were significantly enriched.
The 28 detox genes found inside CNVs were predominantly ones that have previously been implicated in insecticide resistance ( 3R), Cyp6z1 (chromosome 3R) and Cyp9k1 (chromosome X) ( Fig. 1a ). Since the Cyp6aa1 / Cyp6aa2 genes, which are adjacent to the Cyp6p cluster, were also highly represented in the list of amplified genes (Supplementary Data S2), we extended the study region around Cyp6p3 to include these genes.
Using discordant read pairs and reads aligning to CNV breakpoints, we found that three of the five gene clusters showed very high numbers of repeated, independent CNV events. We identified 16 This resulted in some genes being amplified at very high frequency in certain populations (Table 3 ).
In particular, over 92% of individuals had a CNV in Cyp9k1 in An. gambiae from Burkina Faso, and 90% of individuals had a CNV covering all genes in the Cyp6p cluster in An. coluzzii from Côte d'Ivoire.
CNVs in metabolic resistance genes are under positive selection
Several CNV alleles were found at high local frequencies (Supplementary Data S8), suggesting that they are likely to be under positive selection. To investigate this possibility, we phased the CNV genotype calls onto the Ag1000G phase 2 haplotype scaffold and calculated extended haplotype heterozygosity (EHH) for the CNV alleles present in at least 5% of individuals in a population.
Rates of EHH decay around CNV alleles were consistently lower than for wild-type haplotypes haplotypes from the same population (bootstrapped 95% confidence intervals for the medians did not overlap, Fig. 3 , S6, S8 and S10).
Phasing of CNV genotype calls was only possible for simple duplications, where the zygosity of the CNV alleles could be determined from the copy number estimates. For CNV alleles with higher copy numbers (triplications and above), this was not possible, and thus the EHH decay could not be calculated. In the case of Cyp9k1, the CNV with the highest frequency (Cyp9k1_Dup11, found in An. gambiae from Burkina Faso, Ghana and Guinea) could not be phased. We therefore investigated whether this CNV was associated, at the sample level, with haplotypes under selection. Hierarchical clustering of the haplotypes in these three populations revealed two large cross-population haplotype clusters around Cyp9k1, indicating selective sweeps ( Fig. S11 ). Cluster 1 was very strongly associated with Cyp9k1_Dup11 in both males (Fisher's exact test, P < 0.0001; Supplementary Table S1 ) and females (Spearman's rank correlation: ρ = 0.9, P < 0.0001, Fig. 4a ).
Cluster 2 was associated with the presence of Cyp9k1_Dup15, but the correlation was not as close as between Cluster 1 and Cyp9k1_Dup11 (Spearman's rank correlation: ρ = 0.65, P < 0.0001, Fig. 4b & Supplementary Table S2 ).
A Gste2 duplication in Burkina Faso is associated with the resistance-conferring I114T mutation.
Ten of the 11 CNV alleles found in the Gstu4 -Gste3 cluster included Gste2 (Fig. 1) , perhaps reflecting the known importance of this gene in insecticide resistance. The well-characterised I114T mutation in Gste2 is known to confer DDT resistance [28] , and could be associated with gene duplications in a similar fashion to other mutations such as the Ace-1 G119S. We therefore investigated whether any of the CNV alleles in Gste2 were associated with this mutation. 114T is present across Africa and in both An. gambiae an An. coluzzii [36] , but was only associated with Gstue_Dup1 in our data. Gstue_Dup1 was found in 16 An. coluzzii samples from Burkina Faso, all of which were at least heterozygote for 114T ( Supplementary Table S3 ). The presence of 114T homozygotes, together with the ratio of reads supporting the I114 and 114T alleles in heterozygotes (roughly 1:2), indicate that both copies of Gste2 in the Gstue_Dup1 CNV carry the 114T mutation.
Cyp6aa1 is more strongly associated with CNVs than

Cyp6p3
Of the 15 CNV alleles found in the Cyp6aa1 -Cyp6p2 cluster, five included included Cyp6aa1 (Supplementary Data S4). Cyp6p3 CNVs were found at high (> 50%) frequency in one population (Côte d'Ivoire An. coluzzii: 90%), while Cyp6aa1 CNVs were found at high frequency in An. coluzzii from Burkina Faso (91%), Côte d'Ivoire (89%) and Guinea (75%), and in An. gambiae from Uganda (64%).
Discussion
Our study detected 1557 CNVs in An. gambiae and An. coluzzii and revealed a striking enrichment for gene families involved in metabolic insecticide resistance. These results mirror findings in Drosophila melanogaster, where cytochrome P450s were disproportionately represented in CNVs [37] . Similarly, in Aedes aegypti, cytochrome P450s were enriched among genes showing evidence of higher copy number in populations resistant to deltamethrin compared to susceptible populations [38] . Strikingly, the five metabolic genes most strongly associated with insecticide resistance in the literature for An. gambiae and An. coluzzii, and which have been shown to metabolise insecticides in vitro (Gste2, Cyp6p3, Cyp6m2, Cyp6z1 and Cyp9k1), were all found to be amplified in at least one population in our dataset. Furthermore, three of these genes showed evidence of repeated independent CNV events within and between populations, with as many as 16 independent CNV alleles in Cyp9k1.
Expression of Gste2 is higher in DDT resistant An. gambiae [39, 40] and An. funestus [41] compared to susceptible mosquitoes, and transgenic expression of An. gambiae / An. funestus Gste2 in
Drosophila provides resistance to DDT [28, 41] . Non-synonymous SNPs in Gste2 have also been shown to be associated with resistance to DDT in both An. gambiae [28] and An. funestus [41] . In our study, Gste2 was amplified in Kenya, in An. coluzzii from Angola, Burkina Faso and Ghana, and in An. gambiae from Gabon and Uganda.
Cyp6p3 is up-regulated in mosquitoes resistant to pyrethroids, DDT and bendiocarb [29, 30, [42] [43] [44] [45] , metabolises permethrin and deltamethrin [30] and provides resistance to pyrethroids when expressed in Drosophila [29] . Cyp6m2 is also up-regulated in mosquitoes with resistance to permethrin, DDT and bendiocarb [29, 31, 42, 46] , metabolises pyrethroids and DDT [31, 32] and provides resistance to pyrethroids, DDT and bendiocarb when expressed in Drosophila [29] . In our study, Cyp6p3 and Cyp6m2 were found amplified primarily in An. coluzzii from Côte d'Ivoire.
Interestingly, mosquitoes from the Côte d'Ivoire population that our samples were drawn from overexpress both Cyp6p3 and Cyp6m2 compared to susceptible populations [29] . Particularly in the case of Cyp6m2, this over-expression is unlikely to be driven solely by CNVs, since the CNV frequency and copy number are not sufficient to explain the expression levels, but the selective pressure to up- regulate these genes may have played a part in maintaining these CNVs in the population.
Cyp6z1 was amplified in An gambiae from Burkina Faso and Guinea. Cyp6z1 is up-regulated in mosquitoes with resistance to pyrethroids and DDT [39, 47] and metabolises DDT and carbaryl [33] .
Finally, Cyp9k1 was the most widely amplified gene of the five, with CNVs found in over half of the populations in our dataset. Cyp9k1 is up-regulated in mosquitoes resistant to pyrethroids and DDT [44, 45, 48] , and metabolises deltamethrin [35] . Furthermore, a selective sweep in the Cyp9k1 region has been associated with insecticide resistance in An. coluzzii [34] .
In-depth investigation of the CNVs around these five genes revealed strong evidence that they provide a selective advantage. First, some of the CNV alleles were found at high frequencies and across several populations. Second, the CNV alleles consistently showed evidence of being under positive selection as haplotype homozygosity was extended further for the CNVs than for wild-type haplotypes. Evidence for positive selection was also found in a CNV where the EHH score could not be calculated. Cyp9k1_Dup11, which exists as both duplications and triplications and thus could not be phased onto a haplotype scaffold for homozygosity calculation, was consistently found in the same samples as the haplotype of a large selective sweep around Cyp9k1 in An. gambiae from Burkina Faso, Guinea and Ghana, raising the strong possibility that this CNV is the focus of the selective sweep. It cannot be excluded that Cyp9k1_Dup11 is in linkage disequilibrium with another mutation that is driving the sweep. However, the high frequency of the triplicated version of Cyp9k1_Dup11 compared to the duplicated version, both of which are associated with the swept haplotype cluster, suggests that higher-order amplifications of Cyp9k1 provide a selective advantage. The changes in allele frequencies in the different amplification levels in this CNV will need to be monitored to determine whether the triplication eventually replaces the duplication entirely.
We found multiple independent CNVs in three of the five gene regions, with 11 CNV alleles around All but one of the eleven CNV alleles in the Gstu/e cluster included Gste2, indicating that this is the major target of gene amplification in this cluster. Given the body of evidence linking Gste2 to DDT and pyrethroid resistance across multiple species (An. gambiae: [28] , An. funestus: [41] , Aedes aegypti: [49] ), the focus of amplifications on this gene is likely to be linked to its importance in resistance. Interestingly, the Gstue_Dup1 duplication in Burkina Faso occurs on the background of the Gste2_114T SNP, associated with DDT resistance in An. gambiae [28] . The duplication may therefore serve to increase the dosage of Gste2, whose detoxifying activity has already been elevated by the 114T mutation. Alternatively, the role of Gstue_Dup1 may be to compensate for any negative fitness effects of 114T. Whilst impaired Gste2 activity may be compensated by increasing the expression of the gene, Gstue_Dup1 is homogeneous for 114T, excluding the possibility of compensation by pairing of mutant and wild-type alleles as found in heterogeneous Ace-1 duplications [6] . [43, 48] . There is also strong evidence for a link between Cyp6aa1 and insecticide resistance in two congeneric species. In An. funestus expression of Cyp6aa1 is higher in mosquitoes that have survived permethrin exposure compared to a susceptible strain [50, 51] , and the protein has been shown to metabolise pyrethroids and drive resistance when expressed in Drosophila [50] . In An. minimus, the ortholog of Cyp6aa1 is upregulated as a result of selection for resistance to deltamethrin [52] , and the protein has been shown to metabolise pyrethroids [53] . The ability of An. gambiae Cyp6aa1 to metabolise insecticides has not been tested empirically, although theoretical modelling suggests that it should effectively bind to permethrin and deltamethrin [50] . The high frequency of amplifications in Cyp6aa1 and the signals of selection associated with them suggest that the importance of this gene for insecticide resistance in An. gambiae and An. coluzzii has been under-appreciated.
In conclusion, our results show a key role for CNVs in the adaptive response to strong and evolutionary recent selective pressure. In populations of Anopheles mosquitoes across Africa, genes involved in metabolic resistance to insecticides have been duplicated and these duplications have removed by purifying selection. Our findings also highlight Cyp6aa1 as a gene that should be more closely investigated for its importance in An. gambiae, having been so far overlooked in preference to its genomic neighbour Cyp6p3. More broadly, the focus on SNPs in An. gambiae insecticide resistance research has allowed the emergence and selective spread of copy number mutations in key insecticide resistance genes to go unnoticed. Our findings demonstrate the importance of surveillance and investigation of CNVs in these genes. To this end, the breakpoint descriptions provided in our study will allow these CNVs to be screened and monitored in mosquito populations, allowing the spread of these mutations to be tracked and providing the groundwork for future studies investigating their resistance profile.
Methods
Population sampling and whole genome sequencing
We analysed data from 1,142 individual wild-caught specimens of An. gambiae and An. coluzzii collected and sequenced in phase 2 of Ag1000G [13] . The specimens were collected from sites in 
Calculation and normalisation of coverage
For each individual, we used the pysam software package (https://github.com/pysamdevelopers/pysam) to count the number of aligned reads (coverage) in non-overlapping 300 bp windows over the nuclear genome. The position of each read was considered to be its alignment start point, thus each read was only counted once. Sequencing coverage can be biased by variation in local nucleotide composition. To account for this, we computed a normalised coverage from the read counts based on the expected coverage of each window given its GC content [54] . For each 300 bp window we computed the percentage of (G+C) nucleotides to the nearest percentage point within the reference sequence and then divided the read counts in each window by the mean read count over all autosomal windows with the same (G+C) percentage. To minimise the impact of copy number variation when calculating these normalising constants, we excluded windows from the calculation of mean read counts where previous analyses of genome accessibility have found evidence for excessively high or low coverage or ambiguous alignment (windows with <90% accessible bases according to the Ag1000G phase 2 genome accessibility map [13] , referred to as "accessible windows"). The normalised coverage values were then multiplied by a factor of 2, so that genome regions with a normal diploid copy number should have an expected normalised coverage of 2.
Before examining the normalised coverage data for evidence of copy number variation, we applied two filters to exclude windows where coverage may be an unreliable indicator of copy number. The first filter removed windows where more than 2% of reads were aligned with mapping quality 0 ( Fig. S12) , which indicates that a read is mapped ambiguously and could be mapped equally well to Windows retained for analysis were referred to as "filtered windows".
Genome-wide copy number variation discovery
To detect the most likely copy-number state (CNS) at each window in each individual, we applied a Gaussian Hidden Markov Model (HMM) to the individual's normalised windowed coverage data, following a similar approach to [55] and [5] (see Supplementary Methods SM1 for details). Since we are primarily interested in amplifications rather than deletions, we obtained a raw set of CNV calls for each sample by locating contiguous runs of at least five windows with amplified CNS (CNS > 2, or CNS > 1 for chromosome X in males).
CNV filtering
We then applied two filters to the raw CNV calls from these 1,115 samples. For the first filter, we computed likelihoods for each raw CNV call for both the copy number state predicted by the HMM and for a null model of copy number = 2, and removed CNV calls where the likelihood ratio was < Methods SM2) . For the second filter, we removed CNVs with low population frequencies.
(Supplementary
To do this, the raw CNV calls needed to be matched so that the same CNV in different individuals could be identified. We classed any two CNVs as identical if the breakpoints predicted by their copy number state transitions were within one window of each-other. We then removed CNVs that were not found in at least 5% of individuals in at least one population (or at least 3 individuals for populations smaller than 40).
Discovery of gene duplications and gene enrichment analysis
To determine the genes contained within each CNV, we compared the start and end points of the CNVs to the start and end points of all genes listed in the AgamP4.2 gene annotations (Anophelesgambiae-PEST_BASEFEATURES_AgamP4.2.gff3). The start / end points of each CNV were calculated as the median of the start / end points of all the raw CNV calls that were matched to it. To keep only genes for which good coverage data were available, we retained only genes containing at least 50% filtered windows. We classed a retained gene as copied by a CNV if all of the filtered windows within the gene were inside the CNV. We performed simulations to determine whether the CNVs that we detected contained more genes than expected by chance. For each run of the simulation, we randomly re-allocated the start positions of every detected CNV, keeping the number of filtered windows covered by the CNVs unchanged, and calculated the number of CNVs that included at least one gene. This simulation was run 10,000 times to obtain the distribution of the null model.
We identified genes that could potentially be involved in metabolic resistance through detoxification ("metabolic detox genes") by finding genes whose annotations contained the terms "P450", "glutathione S-transferase" or "carboxylesterase" in the AgamP4 transcript annotations (Anopheles-gambiae-PEST_TRANSCRIPTS_AgamP4.2.fa). We performed simulations to determine whether genes copied by CNVs were enriched for detox genes. For each run of the simulation, we randomly re-allocated the genes encompassed by each CNV, keeping the number of consecutive genes covered by each CNV unchanged, and calculated the number of CNVs that included at least one metabolic detox gene. This simulation was run 10,000 times to obtain the distribution of the null model. False discovery rates were calculated from the P-values using the R package fdrtool [57] .
Identifying CNV alleles at candidate metabolic insecticide resistance loci
We characterised in detail the independent duplication events (CNV alleles) at five gene clusters of
Cyp9k1) using their unique patterns of discordant read pairs and reads crossing the CNV breakpoint (breakpoints reads, see Supplementary Methods SM3 and Fig. 5 ). We manually inspected the five regions of interest in all 1142 samples to identify patterns of discordant and breakpoint reads ("diagnostic reads") consistently associated with changes in coverage ( Supplementary Fig. S1-S4) .
The start and end point of each CNV allele could usually be precisely determined by the breakpoint reads, and was otherwise determined by discordant read pairs or the point of change in coverage (Supplementary Data S4-S7). Once the diagnostic reads were identified for a CNV allele, we recorded the presence of that allele in all samples with at least two supporting diagnostic reads.
Detecting signals of selection on CNV alleles
We used the phased haplotypes to calculate the pairwise shared haplotype length and the EHH for each CNV allele [58] , using only SNPs from outside the region in which CNVs were found. EHH calculations were performed using the scikit-allel Python package [ref] .
Haplotypes clusters in the Cyp9k1 region were were obtained with scikit-allel, using the first 1000
SNPs on the centromeric side of Cyp9k1 (the telomeric side of this gene has low levels of accessibility). A distance matrix between haplotypes was computed using the proportion of accessible SNPs that differed between pairwise haplotype combinations. This was used to perform hierarchical clustering, with haplotype clusters defined using a cut-off of 0.001.
Statistics
Statistical analysis was performed in R [59] . Contingency tables were analysed with Fisher's exact test. Where the sample size was too large for the Fisher's exact test, P values were obtained using the "simulated.p.value" option with 10 6 replicates.
Estimating allele-specific copy numbers and phasing CNV genotypes onto the Ag1000G haplotype scaffolds
To determine the allele-specific copy number in a sample, we estimated the change in coverage associated with each CNV allele (Supplementary Methods SM4 and Fig. S14 ). Thus, even when overlapping CNV alleles were present in a single sample, we were usually able to determine the number of copies of each allele.
For single-copy CNVs, it is possible to determine the genotype of a sample from the copy numbers (copy numbers of 1 indicate a heterozygote, copy numbers of 2 indicate a homozygote for the CNV). For higher-order CNVs, this is not possible because a heterozygote triplication cannot be distinguished from a homozygote duplication. We therefore applied two filters to retain only singlecopy CNV alleles. The first filter removed CNV alleles where the allele-specific copy number was found to rise above 2 in the data (if only a single sample rose as high as 2.5, we assumed that this could be an error and classed it as 2). This filter removed five CNV alleles (Cyp6aap_Dup11, Gstue_Dup2, Gstue_Dup8, Cyp9k1_Dup11, Cyp9k1_Dup15). For the second filter, we classed each sample as homozygote wild-type, heterozygote or homozygote CNV based on their copy numbers, and then removed CNV alleles that were inconsistent with Hardy-Weinberg expectations within the populations in which they were found. This filter removed four CNV alleles (Cyp6aap_Dup4, Gstue_Dup5. Gstue_Dup7, Cyp9k1_Dup10). Three CNV alleles (Cyp9k1_Dup7, Cyp9k1_Dup13
and Cyp9k1_Dup14) were also excluded because of difficulties in calling allele-specific copy number (Supplementary Data S7). In one case (Cyp6m2_Dup1), all individuals were found to have a copy number of 2, indicating that the CNV is a triplication, with no duplications present in the population. This CNV was therefore retained, with all samples carrying the CNV classed as heterozygote.
CNV alleles that passed both filters were phased onto the Ag1000G phase 2 haplotype scaffolds using the MVNCALL software v1.0 [60] , using default parameters apart from setting λ = 0.1 to ensure that none of the input CNV genotype calls were changed during phasing. For each of the five gene clusters, phasing was performed using the 200 non-singleton SNPs either side of the region in which CNVs were found, thus avoiding the inclusion of SNPs found inside any of the CNVs.
Haplotypes that contained more than one CNV allele were rare and therefore excluded from subsequent calculations of haplotype heterozygosity. c In deletions, read pairs derived from segments spanning the deleted sequence (red arrows) align in the correct orientation around the breakpoint, but farther apart than expected given the insert size of the sequencing library (green arrows). d In any of the above types of CNV (tandem duplication shown here as an example), reads crossing the breakpoint (red arrow) will only partially align on either side of the breakpoint. For the tandem duplication shown here, the start of the read (light brown start of an arrow) aligns at the end of the duplicated region, while the end of the read (dark brown end of an arrow) aligns at the start of the duplication. Chromosome 2L Chromosome 2R Chromosome 3R Chromosome X Gene ID Annotation Gene ID Annotation Gene ID Annotation Gene ID Annotation AGAP006724 COEAE3G AGAP002862 CYP6AA1 AGAP008022 CYP12F1 AGAP000818 CYP9K1 AGAP006725 COEAE3H AGAP013128 CYP6AA2 AGAP008212 CYP6M2 AGAP006726 COEAE5G AGAP002863 COEAE6O AGAP008219 CYP6Z1 AGAP006727 COEAE6G AGAP002865 CYP6P3 AGAP009190 GSTE8 AGAP006728 COEAE7G AGAP002866 CYP6P5 AGAP009191 GSTE6 AGAP002867 CYP6P4 AGAP009192 GSTE5 AGAP002868 CYP6P1 AGAP009193 GSTE4 AGAP002869 CYP6P2 AGAP009194 GSTE2 AGAP002870 CYP6AD1 AGAP009195 GSTE1 AGAP004165 GSTD2 AGAP009196 GSTE7 AGAP009197 GSTE3 AGAP009696 CYP325C3 Table 3 : Number (and proportion) of individuals with a CNV covering Cyp6aa1, Cyp6p3, Gste2, Cyp6m2, Cyp6z1 or Cyp9k1. CNVs were identified using discordant and breakpoint reads. AO = Angola, BF = Burkina Faso, CI = Côte d'Ivoire, CM = Cameroon, FR = French Mayotte, GA = Gabon, GH = Ghana, GM = The Gambia, GN = Guinea, GQ = Equatorial Guinea, GW = Guinea-Bissau, KE = Kenya, UG = Uganda. col = An. coluzzii, gam = An. gambiae. Numbers in brackets after the population name indicate the total number of samples from that population. Proportions above 50% have been highlighted in bold. 
